Holen Sie sich die Stockscreener-App
0.7765
0.46%
-0.0036
Handel nachbörslich:
.80
0.0235
+3.03%
Atossa Therapeutics Inc Aktie (ATOS) Neueste Nachrichten
Trendlines Converge — Decision Point for Atossa Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Opportunities - beatles.ru
What recovery options are there for Atossa Therapeutics Inc.Quarterly Trade Report & Smart Swing Trading Techniques - Newser
Published on: 2025-08-15 04:52:23 - Newser
Will Atossa Therapeutics Inc. benefit from macro trendsEarnings Trend Report & Long Hold Capital Preservation Plans - Newser
Why Atossa Therapeutics Inc. stock attracts strong analyst attentionWeekly Risk Report & Risk Controlled Daily Plans - Newser
What makes Atossa Therapeutics Inc. stock price move sharplyBuy Signal & Low Drawdown Trading Strategies - Newser
What the charts say about Atossa Therapeutics Inc. todayVolume Spike & Weekly Chart Analysis and Trade Guides - Newser
Technical analysis overview for Atossa Therapeutics Inc. stock - Newser
Should you wait for a breakout in Atossa Therapeutics Inc.IPO Watch & Low Drawdown Investment Strategies - Newser
Ranking Atossa Therapeutics Inc. among high performing stocks via toolsTrade Analysis Summary & AI Optimized Trade Strategies - Newser
Atossa Therapeutics Advances Breast Cancer Treatments - TipRanks
What does recent volatility data suggest for Atossa Therapeutics Inc. [July 2025 News Drivers]Weekly Breakout Opportunity Watchlist - Newser
Can momentum traders help lift Atossa Therapeutics Inc.Short-Term Price Breakout Signal Analysis - Newser
Atossa Therapeutics Inc. stock momentum explainedDaily Breakout List with Smart Filters - Newser
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Applying sector rotation models to Atossa Therapeutics Inc. [July 2025 Rallies]Risk Controlled Stock Pick Alerts - Newser
Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Short Term Charts Align With Long Term Uptrend in Atossa Therapeutics Inc.Growth Based Stock Signal Screener Updated - 선데이타임즈
Atossa Therapeutics' Q2 2025 Earnings: Navigating Financial Losses and the Promise of (Z)-endoxifen in Metastatic Breast Cancer - AInvest
Atossa Therapeutics Q2 2025 Financial Results and Corporate Update - TradingView
FDA Fast-Tracks Atossa's Breast Cancer Drug as Clinical Trial Shows 77% Tumor Reduction - Stock Titan
Risk vs reward if holding onto Atossa Therapeutics Inc.Free Pattern Alert With ROI Driven Strategy - Newser
Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update - Ariva
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pensacola News Journal
How moving averages guide Atossa Therapeutics Inc. tradingEquity Market Return Forecast Model Update - Newser
New Product Launches: Will They Boost Atossa Therapeutics Inc. Stock in 2025Free Sector Rotation Based Trading Opportunities - Newser
Is Atossa Therapeutics Inc. building a consolidation baseTrade Signal Summary & Consistent Profit Trade Alerts - Newser
What does recent volatility data suggest for Atossa Therapeutics Inc.Secure Trading Strategy Based on Technical Analysis - Newser
Atossa Therapeutics Inc. Uptrend in Early Stages Indicators Say YesReversal Alert Based on RSI Indicator Confirmed - beatles.ru
Published on: 2025-08-09 01:47:05 - Newser
Does Atossa Therapeutics Inc. show high probability of reboundFree Consistent Gain Investment Strategies - Newser
Atossa Genetics (ATOS) Expected to Announce Earnings on Monday - Defense World
Atossa Therapeutics Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Published on: 2025-08-05 01:42:52 - Newser
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):